首页> 外文OA文献 >Staged Mucosal Advancement Flap versus Staged Fibrin Sealant in the Treatment of Complex Perianal Fistulas
【2h】

Staged Mucosal Advancement Flap versus Staged Fibrin Sealant in the Treatment of Complex Perianal Fistulas

机译:阶段性粘膜推进皮瓣与阶段性纤维蛋白封闭剂治疗复杂性肛周瘘管

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. In this prospective randomised study, the staged mucosal advancement flap is compared with staged fibrin sealant application in the treatment of perianal fistulas. Methods. All patients with high complex cryptoglandular fistulas were randomised to closure of the internal opening by a mucosal advancement flap (MF) or injection with fibrin sealant (FS) after treatment with setons. Recurrence rate and incontinence disorders were explored. Results. The MF group (5 females and 10 males) with a median age of 51 years and a median followup of 52 months. The FS group (4 females and 11 males) with a median age of 45 years and a median followup of 49 months. Three (20%) patients of the MF group had a recurrent fistula compared to 9 (60%) of the FS group (P = 0.03). No new continence disorders developed. Conclusion. Staged FS injection has a much lower success rate compared to MF.
机译:背景。在这项前瞻性随机研究中,将阶段性粘膜推进皮瓣与阶段性纤维蛋白封闭剂在肛周瘘管治疗中的应用进行了比较。方法。所有患有高复杂性隐腺瘘的患者均被随机分为两组,一组是粘膜推进皮瓣(MF),另一组是用纤维蛋白封闭剂(FS)注射。探讨了复发率和失禁障碍。结果。 MF组(5名女性和10名男性)中位年龄为51岁,中位随访时间为52个月。 FS组(4名女性和11名男性)中位年龄为45岁,中位随访时间为49个月。 MF组有3例(20%)复发性瘘,而FS组有9例(60%)(P = 0.03)。没有新的节制障碍的发展。结论。与MF相比,分段FS注射的成功率要低得多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号